Vaccine against fatal salmonella moves closer

A vaccine against a fatal strain of salmonella could be developed thanks to research led by Dr Calman MacLennan from the University of Birmingham.

His research team has discovered a protective salmonella-specific antibody that develops in African children that may help them to fight nontyphoidal salmonella, which can kill up to a quarter of infants under two-years-old in parts of the developing world.

Dr Calman MacLennan, who carried out the work while working for the Universities of Liverpool and Malawi, hopes the study will help to develop a vaccine or a treatment for the disease.

 For more details see the University of Birmingham.  

Advertisements

Midlands winner of science medal

Aston University’s Professor Yvonne Perrie has been announced as the 2007 winner of the prestigious British Pharmaceutical Conference science medal, primarily for her work in improving the delivery of drugs using minute particles called liposomes.

The science medal is awarded annually to a scientist working in a pharmaceutical or related discipline who has produced work of outstanding promise and has demonstrated a proven track record of independent research.

Her research has been applied to improve the potency of drugs while reducing their side-effects and in particular to enhancing the effect of vaccines to protect against a range of infectious diseases.

For more details see Aston University

Alzheimer’s patients have high levels of magnetic iron oxides

Higher than normal levels of magnetic iron oxides are present in Alzheimer patients, researchers at Keele University have discovered.

The results of a small scale study of Alzheimer patients indicates that iron accumulation associated with Alzheimer’s appears to involve the formation of strongly magnetic iron compounds.

The findings could lead to a method of diagnosing the disease using an MRI scan.

For more see Keele University.

Spur to Parkinson’s treatment

Possible new treatments for Parkinson’s disease could result from a new three-year research project at Aston University, which has just been given £200,000 funding by the Parkinson’s Disease Society.

The study aims to understand better and improve electoral stimulation therapies that are used as a treatment of Parkinson’s disease.

For more details see Aston University.